DrugPatentWatch Database Preview
Sagent Pharms Company Profile
What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?
SAGENT PHARMS has sixty-eight approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Summary for Sagent Pharms
| US Patents: | 0 |
| Tradenames: | 55 |
| Ingredients: | 52 |
| NDAs: | 68 |
Drugs and US Patents for Sagent Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-002 | Jul 18, 2011 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sagent Pharms | OCTREOTIDE ACETATE (PRESERVATIVE FREE) | octreotide acetate | INJECTABLE;INJECTION | 090834-001 | Nov 12, 2013 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sagent Pharms | VECURONIUM BROMIDE | vecuronium bromide | INJECTABLE;INJECTION | 078274-002 | Dec 29, 2008 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Sagent Pharms | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-003 | Jul 18, 2011 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
